Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who experience typical or atypical chest pain, or symptoms that may suggest reduced blood flow to the heart, including shortness of breath
- People whose coronary angiogram or CT scan has shown no significant blockages in the heart's arteries (less than 50% narrowing)
Who may not be able to join:
- People who have moderate or severe heart valve disease
- People who were born with a structural heart defect (congenital heart disease)
- People with significantly reduced kidney function (confirm with trial site) or those whose kidneys have failed and who are currently on dialysis
- People who have asthma, chronic obstructive pulmonary disease (such as emphysema or chronic bronchitis), or high blood pressure in the lungs that is not caused by another condition
- People who are currently receiving cancer treatment drugs
- People who have inflammation of blood vessels caused by an autoimmune disease
- People who have certain heart rhythm problems, including a significant blockage in the heart's electrical system, a slow heart rate causing symptoms, a condition where the heart's natural pacemaker does not work properly, or a condition called Wolff-Parkinson-White syndrome
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Seong-Mi Park, PhD, Korea University Anam Hospital
Phone: 82-10-9453-4810
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
A composite outcome including all-cause mortality, nonfatal myocardial infarction, nonfatal stroke, and hospitalization for heart failure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.